ctrl K

Ginkgo Bioworks Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

7.00

-0.37 (-5.02%)

At close: May 01, 2025, 3:59 PM

7.21

2.97%

Pre-market: May 02, 2025, 09:12 AM EDT

Ginkgo Bioworks Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	227.04M	251.46M	477.71M	313.84M	76.66M	54.18M
Cost of Revenue	38.55M	54.01M	204.22M	129.69M	15.61M	n/a
Gross Profit	188.49M	197.45M	273.49M	184.15M	61.05M	54.18M
Operating Income	-559.76M	-864.41M	-2.21B	-1.83B	-137.03M	-71.6M
Interest Income	38.61M	57.22M	20.26M	837K	2.58M	5.76M
Pretax Income	-547.51M	-892.94M	-2.12B	-1.84B	-124.83M	-119.83M
Net Income	-547.03M	-892.87M	-2.1B	-1.83B	-126.61M	-119.33M
Selling & General & Admin	246.16M	385.02M	1.43B	862.95M	38.31M	29.48M
Research & Development	424.06M	580.62M	1.05B	1.15B	159.77M	96.3M
Other Expenses	78.03M	96.21M	7.63M	-1.73M	16.13M	1.57M
Operating Expenses	748.25M	1.06B	2.48B	2.01B	198.07M	125.78M
Interest Expense	94K	93K	106K	2.37M	2.38M	2.42M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	786.8M	1.12B	2.69B	2.14B	213.68M	125.78M
Income Tax Expense	-479K	-71K	-15.03M	-1.48M	1.89M	22K
Shares Outstanding (Basic)	51.89M	48.53M	41.93M	32.95M	31.65M	28.73M
Shares Outstanding (Diluted)	51.89M	48.61M	42M	34.01M	31.87M	28.73M
EPS (Basic)	-10.54	-18.37	-50.15	-53.83	-3.97	-4.15
EPS (Diluted)	-10.54	-18.4	-50.2	-55.53	-4	-4.15
EBITDA	-484.39M	-821.29M	-2.06B	-1.81B	-108.58M	-106.66M
EBIT	-547.41M	-892.85M	-2.12B	-1.84B	-122.45M	-117.41M
Depreciation & Amortization	63.02M	71.55M	61.63M	29.08M	13.86M	10.76M